Filtered By:
Management: Managed Care
Therapy: Neoadjuvant Therapy
This page shows you your search results in order of date.
Order by Relevance | Date
Total 21 results found since Jan 2013.
Evaluation of biosimilar trastuzumab MYL-1401O in HER2-positive breast cancer
CONCLUSIONS: These data suggest that biosimilar trastuzumab MYL-1401O has similar effectiveness and cardiac safety to RTZ in patients with HER2-positive EBC or MBC.PMID:36811986 | DOI:10.37765/ajmc.2023.89234
Source: The American Journal of Managed Care - February 22, 2023 Category: Health Management Authors: Kadir Eser Emel Sezer Vehbi Er çolak Ali İnal Source Type: research
